Dose response, recovery, and cost of doxacurium as a continuous infusion in neurosurgical intensive care unit patients

Critical Care Medicine

Volumn 25, Issue 7, 1997, Pages 1236-1241

  Prielipp, Richard C ^a   Robinson, James C ^a   Wilson, John A ^a   MacGregor, Drew A ^a   Scuderi, Phillip E ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Doxacurium; Drug cost; Drug therapy; Intensive care unit; Intracranial pressure; Muscle relaxants; Neuromuscular blocking drugs; Neurosurgery; Paralytic agents

Indexed keywords

DIMETHYLTUBOCURARINE CHLORIDE; DOXACURIUM;

ADULT; ARTICLE; BLOOD PRESSURE; BRAIN INJURY; BRAIN SURGERY; CLINICAL ARTICLE; COST BENEFIT ANALYSIS; CRITICAL ILLNESS; DRUG CHOICE; DRUG COST; DRUG EFFECT; FEMALE; HEART RATE; HUMAN; INTENSIVE CARE; INTRACRANIAL PRESSURE; MALE; MUSCLE RELAXATION; NEUROMUSCULAR BLOCKING; PRIORITY JOURNAL; TREATMENT PLANNING;

ADULT; BLOOD PRESSURE; BRAIN INJURIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART RATE; HUMANS; INFUSIONS, INTRAVENOUS; INTENSIVE CARE; INTRACRANIAL PRESSURE; ISOQUINOLINES; MALE; MIDDLE AGED; NEUROMUSCULAR NONDEPOLARIZING AGENTS; NEUROSURGERY; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL;

EID: 0030797179     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199707000-00028     Document Type: Article

References (37)

1. Coursin DB, Kelly JS, Prielipp RC: Muscle relaxants in critical care. Current Opinion in Anaesthesiology 1993; 6:341-346
2. Prielipp RC, Coursin DB, Scuderi PE, et al: Comparison of the infusion requirements and recovery profiles of vecuronium and cisatracurium 51W89 in intensive care unit patients. Anesth Analg 1995; 81:3-12
3. Harper NJ: Neuromuscular blocking drugs: Practical aspects of research in the intensive care unit. Intensive Care Med 1993; 19(Suppl 2):S80-S85
4. Miller RD: Use of neuromuscular blocking drugs in intensive care unit patients. Anesth Analg 1995; 81:1-2
5. Bolton CF: Muscle weakness and difficulty in weaning from the ventilator in the critical care unit. Chest 1994; 106:1-2
6. Coursin DB: Neuromuscular blockade: Should patients be relaxed in the ICU? Chest 1992; 102:988-989
7. Danon MJ, Carpenter S: Myopathy with thick filament (myosin) loss following prolonged paralysis with vecuronium during steroid treatment. Muscle Nerve 1991; 14:1131-1139
8. Hansen-Flaschen J, Cowan J, Raps EC: Neuromuscular blockade in the intensive care unit. More than we bargained for. Am Rev Respir Dis 1993; 147: 234-237
9. Hoyt JW: Persistent paralysis in critically ill patients after the use of neuromuscular blocking agents. New Horiz 1994; 2:48-55
10. Segredo V, Caldwell JE, Matthay MA, et al: Persistent paralysis in critically ill patients after long-term administration of vecuronium. N Engl J Med 1992; 327:524-528
11. Hunter JM: New neuromuscular blocking drugs. N Engl J Med 1995; 332: 1691-1699
12. Meyer KC, Prielipp RC, Grossman JE, et al: Prolonged weakness after infusion of atracurium in two intensive care unit patients. Anesth Analg 1994; 78: 772-774
13. Watling SM, Dasta JF: Prolonged paralysis in intensive care unit patients after the use of neuromuscular blocking agents: A review of the literature. Crit Care Med 1994; 22:884-893
14. Erkola O: Complications of neuromuscular blockers: Interaction with concurrent medications and other neuromuscular blockers. Anesthesiology Clinics of North America 1993; 11(2): 426-444
15. Coursin DB, Meyer DA, Prielipp RC: Doxacurium infusion in critically ill patients with atracurium tachyphylaxis. Am J Health Syst Pharm 1995; 52:635-639
16. Prielipp RC, Coursin DB: Sedative and neuromuscular blocking drug use in critically ill patients with head injuries. New Horiz 1995; 3:456-468
17. Hsiang JK, Chestnut RM, Crisp CB, et al: Early, routine paralysis for intracranial pressure control in severe head injury: Is it necessary? Crit Care Med 1994; 22:1471-1476
18. Prough DS, Joshi S: Does early neuromuscular blockade contribute to adverse outcome after acute head injury? Crit Care Med 1994; 22:1349-1350
19. Barohn RJ, Jackson CE, Rogers SJ, et al: Prolonged paralysis due to non-depolarizing neuromuscular blocking agents and corticosteroids. Muscle Nerve 1994; 17:647-654
20. Op de Coul AA, Lambregts PC, Koeman J, et al: Neuromuscular complications in patients given Pavulon® (pancuronium bromide) during artificial ventilation. Clin Neurol Neurosurg 1985; 87:17-22
21. Wilson JA, Branch CL Jr: Neuromuscular blockade in head-injured patients with increased intracranial pressure: Continuous versus intermittent use. J Neurosurg Anesthesiol 1994; 2:139-141
22. Basta SJ, Savarese JJ, Ali HH, et al: Clinical pharmacology of doxacurium chloride. A new long-acting non-depolarizing muscle relaxant. Anesthesiology 1988; 69:478-486
23. Lennon RL, Hosking MP, Houck PC, et al: Doxacurium chloride for neuromuscular blockade before tracheal intubation and surgery during nitrous oxide-oxygen-narcotic-enflurane anesthesia. Anesth Analg 1989; 68:255-260
24. Stoops CM, Curtis CA, Kovach DA, et al: Hemodynamic effects of doxacurium chloride in patients receiving oxygen sufentanil anesthesia for coronary artery bypass grafting or valve replacement. Anesthesiology 1988; 69:365-370
25. Murray MJ, Coursin DB, Scuderi PE, et al: Double-blind, randomized, multicenter study of doxacurium vs. pancuronium in intensive care unit patients who require neuromuscular-blocking agents. Crit Care Med 1995; 23:450-458
26. Werba A, Weinstabl C, Petricek W, et al: Requisite muscle relaxation using vecuronium for tracheobronchial suction in neurosurgical intensive care patients. Anaesthesist 1991; 40:328-331
27. Knaus WA, Draper EA, Wagner DP, et al: APACHE II: A severity of disease classification system. Crit Care Med 1985; 13:818-829
28. Fernando PU, Viby-Mogensen J, Bonsu AK, et al: Relationship between posttetanic count and response to carinal stimulation during vecuronium-induced neuromuscular blockade. Acta Anaesthesiol Scand 1987; 31:593-596
29. Jensen E, Viby-Mogensen J, Bang U: The Accelograph™ : A new neuromuscular transmission monitor. Acta Anaesthesiol Scand 1988; 32:49-52
30. Katz JA, Fragen RJ, Shanks CA, et al: Dose-response relationships of doxacurium chloride in humans during anesthesia with nitrous oxide and fentanyl, enflurane, isoflurane, or halothane. Anesthesiology 1989; 70:432-436
31. Emmott RS, Bracey BJ, Goldhill DR, et al: Cardiovascular effects of doxacurium, pancuronium, and vecuronium in anaesthetized patients presenting for coronary artery bypass surgery. Br J Anaesth 1990; 65:480-486
32. Werba A, Klezl M, Schramm W, et al: The level of neuromuscular block needed to suppress diaphragmatic movement during tracheal suction in patients with raised intracranial pressure: A study with vecuronium and atracurium. Anaesthesia 1993; 48: 301-303
33. Cook DR, Freeman JA, Lai AA, et al: Pharmacokinetics and pharmacodynamics of doxacurium in normal patients and in those with hepatic or renal failure. Anesth Analg 1991; 72:145-150
34. Marik PE: Doxacurium-corticosteroid acute myopathy: Another piece to the puzzle. Crit Care Med 1996; 24: 1266-1267
35. Prielipp RC, Jackson MJ, Coursin DB: Comparison of the neuromuscular recovery after paralysis with atracurium versus vecuronium in an ICU patient with renal insufficiency. Anesth Analg 1994; 78:775-778
36. Murray MJ, Strickland RA, Weiler C: The use of neuromuscular blocking drugs in the intensive care unit: A US perspective. Intensive Care Med 1993; 19(Suppl 2):S40-S44
37. Muizelaar JP, Marmarou A, Ward JD, et al: Adverse effects of prolonged hyperventilation in patients with severe head injury: A randomized clinical trial. J Neurosurg 1991; 75:731-739